跳至主要内容
临床试验/NCT03010137
NCT03010137终止不适用

Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial

University of California, Davis1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
30
试验地点
1
主要终点
Minor Wound Healing Complications

研究概览

简要总结

Incisional negative pressure therapy (INPWT) has previously been shown in certain patient populations to decrease wound healing complications, decrease the rate of hematomas and seromas, as well as have better scar quality. We have found a group of patients, those who have panniculectomies in preparation for renal transplant, with significantly higher rates of wound healing complications. We believe the best way to demonstrate benefits of incisional negative pressure wound therapy will be in this group of patients known to have significantly higher rates of wound complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •All patients undergoing panniculectomy in preparation for renal transplantation at the University of California Davis Medical Center. Patients who are entered into the trial and have 30 days of follow up, and those in the INPWT study arm who successfully complete 7 days of treatment, will be included.

排除标准

  • •All patients who previously demonstrated a hypersensitivity reaction to adhesives and qualify for panniculectomy in preparation for renal transplantation, or all patients who are undergoing panniculectomy for reasons other than in preparation for renal transplantation (i.e. after massive weight loss or for cosmetic reasons). Patients who do not complete the duration of treatment of negative pressure wound therapy (7 days), or patients who do not follow up for a minimum of 30 days from the date of surgery will be excluded. Adults unable to consent, infants, children, teenagers, pregnant patients and prisoners will be excluded. It is also extremely unlikely, based on our study population, that we will encounter any of these patients.

研究组 & 干预措施

Standard Closure

Placebo Comparator

After surgical closure is complete, the patient receives standard of care operative incision treatment (dermabond/topical skin adhesive).

干预措施: Standard Closure with Skin Glue (Procedure)

Standard Closure

Placebo Comparator

After surgical closure is complete, the patient receives standard of care operative incision treatment (dermabond/topical skin adhesive).

干预措施: Dermabond (Device)

Incisional Negative Pressure Wound Therapy

Active Comparator

After surgical closure is complete, an incisional negative pressure wound therapy device is applied to the incision in its entirety. This device is placed on the wound, sterilely, in the operating room, at the conclusion of the procedure. The incisional negative pressure wound therapy device is to remain in place for 7 days, and is removed in clinic after completion.

干预措施: Incisional Negative Pressure Wound Therapy (Procedure)

Incisional Negative Pressure Wound Therapy

Active Comparator

After surgical closure is complete, an incisional negative pressure wound therapy device is applied to the incision in its entirety. This device is placed on the wound, sterilely, in the operating room, at the conclusion of the procedure. The incisional negative pressure wound therapy device is to remain in place for 7 days, and is removed in clinic after completion.

干预措施: PICO (Smith&Nephew) (Device)

结局指标

主要结局

Minor Wound Healing Complications

时间窗: Up to 3 months after operation

Cellulitis, Seroma, Superficial Wound Separation

Major Wound Healing Complications

时间窗: Up to 3 months after operation

Abscess, Hematoma or any wound complication requiring return to the operating room.

次要结局

  • Time to Drain Removal(Up to 3 months after operation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验